Alexandra Capellini
@acapellini1995
Med-Peds PGY2 @umichmedpeds | MD/MSCR 2023 @IcahnMountSinai | Writer | Adaptive advocate
ID: 31539578
https://www.instagram.com/alexandra.capellini/ 15-04-2009 22:14:48
67 Tweet
128 Takipçi
206 Takip Edilen
Today is my first day as President and CEO of Memorial Sloan Kettering Cancer Center, arguably the world’s leading authority on cancer. Every day, MSK’s exceptional team works tirelessly to do everything possible to help people with cancer. I am proud to now call them my colleagues.
So happy to have attended #ASH2022 with my co-first author Dr. Aaron Etra of Mount Sinai Health System. Presented the results of our phase II trial of itacitinib tx for low risk acute GVHD. Great experience learning about the work of some of the best minds in heme!
Wrote this a while back, but still rings true! | Reflections on personal space by Alexandra Capellini link.medium.com/3WfGu53jnwb
Effective treatment of low-risk acute GVHD with itacitinib monotherapy pubmed.ncbi.nlm.nih.gov/36095841/ Aaron Etra, MD; Alexandra Capellini; James Ferrara, MD; John Levine, MD Icahn School of Medicine at Mount Sinai #GVHD
Hi Blue Cross of Idaho. This is my daughter that you tried to deny care for. When a team of expert Drs recommend a treatment, your PharmD reviewers don’t get to deny her life-saving care for your profits. Your alternative rec: “Talk with your child’s Dr about other options”. What?!
Somehow on my third month here already! Such a great experience so far with Michigan Medicine #MedicinePediatrics! #MichiganMedicine #MedPeds